Major Depressive Disorder (MDD)
The purpose of the study is to determine safety, effectiveness and tolerability of the investigational oral study treatment, versus placebo, as adjunctive therapy in the maintenance treatment of adults with Major Depressive Disorder (MDD). The study will last up to 25 weeks with up to 22 clinic visits. Qualified participants will receive study-related care and medication at no cost, and may be compensated for study-related time and travel.
Male & Female
Why take part?
Participants will receive study-related doctor’s care, study medication at no cost. Compensation for study-related time and travel may be available.Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.
Who is Synexus?
Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.
All Synexus studies are approved by an independent ethics committee.
Recruiting at the following locations
Am I eligible for this study?
To find out, please answer yes or no to the following questions.